China Shineway Pharmaceutical Group Limited (OTCMKTS:CSWYY) Stock Short Interest Falls 47.5%

China Shineway Pharmaceutical Group Limited (OTCMKTS:CSWYY) was the recipient of a large decrease in short interest in the month of September. As of September 30th, there was short interest totaling 155 shares, a decrease of 47.5% from the September 15th total of 295 shares. Based on an average daily volume of 388 shares, the short-interest ratio is presently 0.4 days.

China Shineway Pharmaceutical Group Price Performance

Shares of China Shineway Pharmaceutical Group stock opened at C$21.49 on Wednesday. China Shineway Pharmaceutical Group has a 1 year low of C$18.16 and a 1 year high of C$22.23. The company’s fifty day moving average is C$19.83 and its two-hundred day moving average is C$19.26.

China Shineway Pharmaceutical Group Company Profile

China Shineway Pharmaceutical Group Ltd. is a Chinese pharmaceutical company focused on the development, manufacture and sale of traditional Chinese medicines and related healthcare products. Its portfolio includes prescription and over-the-counter medicines in forms such as injections, capsules, tablets, oral liquids and granules.

The company’s products address a range of therapeutic areas, including respiratory, cardiovascular, digestive and gynecological conditions. Its better-known traditional Chinese medicine products include Qingkailing and Shuanghuanglian formulations, which are marketed in multiple dosage forms.

China Shineway is headquartered in Shijiazhuang, Hebei Province, China, and primarily serves the Chinese pharmaceutical market through hospitals, pharmacies and other healthcare distribution channels.